abstract |
The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. For example, the present invention provides a pharmaceutical composition comprising a compound of the present invention and a pharmaceutically acceptable carrier. For example, according to the present invention, there is also provided a method for treating cancer comprising administering the pharmaceutical composition of the present invention to a patient in need of such treatment. |